Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Equity (2016 - 2025)

Historic Return on Equity for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q1 2025 value amounting to 0.0%.

  • Lifecore Biomedical, Inc. \De\'s Return on Equity fell 400.0% to 0.0% in Q1 2025 from the same period last year, while for Feb 2025 it was 0.0%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.76% for FY2024, which is 16000.0% up from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Return on Equity of 0.0% as of Q1 2025, which was down 400.0% from 0.15% recorded in Q4 2024.
  • Lifecore Biomedical, Inc. \De\'s 5-year Return on Equity high stood at 4.22% for Q4 2023, and its period low was 2.29% during Q2 2023.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Return on Equity averaged around 0.01%, with its median value being 0.07% (2021).
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Return on Equity skyrocketed by 51100bps in 2023 and then tumbled by -40800bps in 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s Return on Equity (Quarter) stood at 0.31% in 2021, then crashed by -183bps to 0.89% in 2022, then soared by 576bps to 4.22% in 2023, then plummeted by -97bps to 0.15% in 2024, then plummeted by -100bps to 0.0% in 2025.
  • Its Return on Equity was 0.0% in Q1 2025, compared to 0.15% in Q4 2024 and 0.22% in Q3 2024.